Nagourney Cancer Institute

Nagourney Cancer Institute At Nagourney Cancer Institute (formerly Rational Therapeutics), we believe that every cancer patient deserves the right treatment the first time, every time.

Your cancer is as unique as your fingerprint. Drugs that work for one patient may not work for another, even if they carry exactly the same diagnosis. We offer testing that measures how your cancer cells will respond to drugs BEFORE you receive them. This testing helps select the most effective and least toxic drug regimen for your cancer. Our founder and medical director, Dr. Robert Nagourney, has been internationally recognized as a pioneer in cancer research and personalized cancer treatment for over 20 years. He has worked 20+ years refining a process that examines the biology of your tumor to identify the most effective, least toxic treatment for YOU. Our patients have been shown to be twice as likely on average to respond to a cancer treatment when chosen in our laboratory compared with standard treatment protocols. With these results, you and your doctors are equipped with personalized information to make the most informed decision to treat YOUR cancer. Truly Personalized Cancer Care.

02/27/2026

At 59, Steve Lockwood was diagnosed with Stage Four Pancreatic cancer.

He was told he likely would not survive the disease.

What followed would become one of the most remarkable examples of laboratory-guided cancer care in our institute’s history. 🩵

This is Steve’s story - Part 1, to be continued.

The AACR meeting continues to reflect the growing focus on understanding how cancers behave during treatment.This shift ...
02/24/2026

The AACR meeting continues to reflect the growing focus on understanding how cancers behave during treatment.

This shift highlights the importance of evaluating individual cancer biology to help guide more personalized care decisions.

At Nagourney Cancer Institute, laboratory analysis plays a central role in helping inform treatment planning based on each patient’s unique disease profile.

Additional context is available in the latest release on our website.

Large-scale evidence presented at AACR underscores the importance of response-guided treatment selection. 🔬Aligned with ...
02/14/2026

Large-scale evidence presented at AACR underscores the importance of response-guided treatment selection. 🔬
Aligned with these findings, research at Nagourney Cancer Institute centers on laboratory evaluation of tumor response to support more informed treatment decisions. The full press release provides additional context:
https://finance.yahoo.com/.../nagourney-cancer-institute...?

Pancreatic cancer has long been treated using drug combinations selected from population-based trials. Research from Nag...
02/13/2026

Pancreatic cancer has long been treated using drug combinations selected from population-based trials. Research from Nagourney Cancer Institute explores laboratory evaluation of patient tumor tissue using FDA-approved therapies to better understand potential treatment response. 🔬

The full press release provides additional context on the data and methodology behind this approach:
https://www.nagourneycancerinstitute.com/media

01/28/2026

Why have outcomes in advanced cancer been so slow to change?
A perspective on treatment priorities and cancer biology.

From the archives (2011).
Dr. Robert A. Nagourney at TEDxSoCal, Part - 2

01/25/2026

Cancer is often described as complex.
But this talk asks a different question - are we truly understanding cancer behavior?

Part 1-From the archives (2011).
Dr. Robert A. Nagourney at TEDxSoCal.

01/17/2026

Cancer biology is not only about proliferation. It is also about impaired cell death.

Tracing the mechanisms behind this failure helps explain why cancers resist treatment and why outcomes can differ so widely. Discover how deeper biological insight supports cancer treatment decisions at NCI. 🔬

01/17/2026

Cancer is not only a disease of uncontrolled growth, it is also a disease of disrupted cellular energy and metabolism.

Cancer cells survive by rewiring how they produce and use energy, often operating under constant metabolic stress. These altered bioenergetic states help explain why cancers adapt, resist treatment, and behave unpredictably.

Studying cancer through this metabolic lens provides critical insight into treatment response and resistance - expanding how clinicians and researchers understand cancer beyond genetics alone.

Learn how this research perspective informs cancer care at Nagourney Cancer Institute.

Not every miracle makes a noise. This holiday season at Nagourney Cancer Institute, we pause to recognize the quiet wins...
12/24/2025

Not every miracle makes a noise. This holiday season at Nagourney Cancer Institute, we pause to recognize the quiet wins - progress made through science, care, and precision.

Wishing strength, clarity, and hope to all this Christmas.🎄❄️

Address

750 E 29th Street
Long Beach, CA
90806

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+18005424357

Website

https://finance.yahoo.com/news/nagourney-cancer-institute-challenge

Alerts

Be the first to know and let us send you an email when Nagourney Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nagourney Cancer Institute:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category